Position
Fidelity in Fulcrum Therapeutics, Inc.
Back to the book · All holders of FULC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$244.8K$7.67 → $3.66
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 7.69K | $87K | — | — | — | 0.0% |
| Q1 2026 | 61K | $468.2K | $7.67 | −$28K | $409.2K | 0.0% |
| Q2 2026 | 92.3K | $337.9K | $3.66 | −$244.8K | $114.5K | 0.0% |